Hanaa A. Ibrahim

Targeting MDR‐1 gene expression, BAX/BCL2, caspase‐3, and Ki‐67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity

Alaa E. El‐Sisi, Samia Salem Sokkar, Hanaa A. Ibrahim et al. · Fundamental and Clinical Pharmacology · 2020 · 39 citations

Pharmacy, Oncology, Pharmacology +17

Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?

Hanaa A. Ibrahim, Manal Baddour, Mona Morsi et al. · Eastern Mediterranean Health Journal · 1999 · 30 citations · Full text

Life Sciences, Dermatology, Immunology +16

Fenofibrate and Diosmetin in a rat model of testicular toxicity: New insight on their protective mechanism through PPAR-α/NRF-2/HO-1 signaling pathway

Moneerah J. Alqahtani, Walaa A. Negm, ‏Hebatallah M. Saad et al. · Biomedicine & Pharmacotherapy · 2023 · 25 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Rosuvastatin and diosmetin inhibited the HSP70/TLR4 /NF-κB p65/NLRP3 signaling pathways and switched macrophage to M2 phenotype in a rat model of acute kidney injury induced by cisplatin

‏Hebatallah M. Saad, Engy Elekhnawy, Moataz A. Shaldam et al. · Biomedicine & Pharmacotherapy · 2024 · 23 citations · Full text

Medicine, Immunology, Pharmacology +17

Therapeutic efficiency of Tamoxifen/Orlistat nanocrystals against solid ehrlich carcinoma via targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 signaling pathways

Thanaa A. El‐Masry, Maysa M. F. El‐Nagar, Ghaleb A. Oriquat et al. · Biomedicine & Pharmacotherapy · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16